Journal article
Towards accredited clinical training in brain stimulation: Proceedings from the Brain Stimulation Subspecialty Summits
Brain stimulation, Vol.18(2), pp.298-305
03/2025
DOI: 10.1016/j.brs.2025.02.012
PMCID: PMC13222746
PMID: 39988120
Abstract
The rapid development and clinical use of brain stimulation has renewed debates about whether to define and accredit a pathway for clinical subspecialty training. To address this, the Brain Stimulation Subspecialty Summits (BraSSS) were convened in 2023 and 2024, featuring international leaders in brain stimulation across psychiatry, neurology, neurosurgery, psychology, and neuroscience. Both meetings included two days of lectures and debates focused on clinical content, emerging science, and educational standards. The 2023 meeting was held at Brigham & Women’s Hospital and Harvard University, where 54 attendees reached a consensus that the subspecialty is adequately developed to warrant formal recognition and initiated debates regarding the name and scope of the subspecialty. The 2024 meeting was held at Stanford University, where 56 attendees developed a content outline, organized committees, and reached a consensus to form an independent society focused on developing and maintaining unbiased accreditation standards. “Brain stimulation” was chosen democratically as the name of the subspecialty. Clinicians from multiple primary specialties may enter this subspecialty training track. While individual programs may have a specific area of focus (e.g. interventional psychiatry or epilepsy), our expectation is that accredited brain stimulation programs will provide training experiences that cross specialties and stimulation modalities. Several potential unintended consequences were discussed, and plans were developed to address them. Overall, subspecialty recognition was deemed to be beneficial to the brain stimulation field, with a goal to launch an associated society and start the process of accrediting existing US and Canadian programs in 2025.
•The Brain Stimulation Subspecialty Summits (BraSSS) convened in 2023 and 2024•Accredited fellowships will offer training in multiple stimulation modalities•Training will be open to psychiatrists, neurologists, neurosurgeons, and others•Goals include improving multidisciplinary education without restricting access•Potential pitfalls were discussed and mitigation plans were developed
Details
- Title: Subtitle
- Towards accredited clinical training in brain stimulation: Proceedings from the Brain Stimulation Subspecialty Summits
- Creators
- Shan H. Siddiqi - Mass General BrighamLeo Chen - Monash UniversityNicholas T. Trapp - University of IowaNoreen Bukhari-Parlakturk - Duke UniversityJoseph J. Taylor - Mass General BrighamAaron D. Boes - University of IowaJoshua C. Brown - McLean HospitalTracy Barbour - Massachusetts General HospitalJoan A. Camprodon - Massachusetts General HospitalMichael D. Fox - Brigham and Women's HospitalBrian H. Kopell - Mount Sinai Health SystemCarlene MacMillan - American Psychiatric AssociationAlfonso Fasano - Toronto Western HospitalRobert S. Fisher - Stanford UniversityZiad Nahas - University of MinnesotaGonzalo J. Revuelta - Ralph H. Johnson VA Medical CenterPatricio Riva-Posse - Emory UniversityJohn D. Rolston - Brigham and Women's HospitalKatherine Scangos - University of PennsylvaniaMouhsin M. Shafi - Berenson Allen Center for Noninvasive Brain StimulationAndrew H. Smith - Mount Sinai Health SystemJoshua Wong - University of FloridaCasey H. Halpern - Osmind, San Francisco, CA, USAHelen S. Mayberg - Icahn School of Medicine at Mount SinaiNolan R. Williams - Stanford University
- Resource Type
- Journal article
- Publication Details
- Brain stimulation, Vol.18(2), pp.298-305
- DOI
- 10.1016/j.brs.2025.02.012
- PMID
- 39988120
- PMCID
- PMC13222746
- NLM abbreviation
- Brain Stimul
- ISSN
- 1935-861X
- eISSN
- 1876-4754
- Publisher
- Elsevier Inc
- Grant note
- National Institute of Mental HealthBrain & Behavior Research FoundationBaszucki Family FoundationBrainsWay Ltd.Neuronetics Inc.Australian Government Department of Health and AgeingBlue Sky FoundationNatwes FoundationNational Institutes of Mental Health: K23MH125145, R01MH125160 Brain and Behavior Research Foundation: 31275, 32270 AE FoundationPaul Penningroth Fellowship in Interventional PsychiatryGerstner FoundationMagnus MedicalFoundation for OCD ResearchDystonia Medical Research FoundationPritzker Neuropsychiatric Disorders Research ConsortiumDoris Duke Charitable FoundationNew Venture FundAmerican Academy of NeurologyWellcome TrustNIH NCATS: 1KL2TR002554 Bayshore Global ManagementChair in Neuromodulation of University Health NetworkUniversity of TorontoNIH: R01MH113929, R21MH126271, R21NS123813, R01NS127892, R01MH130666, UM1NS132358 Kaye Family Research EndowmentEllison/Baszucki Family FoundationManley FamilyNIMHNINDSHope for Depression Research FoundationWellcome LeapNIADepartment of Defense Advanced Research Projects AgencyBrain & Behavior Research FoundationCindy & Paul Gamble FundMarlene Zuckerman FundMcLean Hospital Center of Excellence in Depression and Anxiety DisordersNational Institute of HealthNIH: R01MH112737, R61MH132869, R21AG078692, R21AG081925, R21MH131878, R01MH122754, UG3NS115637, R01MH128311, R01MH118388
SHS is primarily supported by public funds from the National Institute of Mental Health, but also has foundation funds from The Brain & Behavior Research Foundation and the Baszucki Family Foundation, and investigator-initiated grants from BrainsWay Ltd and Neuronetics Inc. LC is supported by project funding from the Australian Government Department of Health and Ageing, and philanthropic funding from the Blue Sky Foundation and the Natwes Foundation. NTT is supported by grants from the National Institutes of Mental Health (K23MH125145 and R01MH125160) and the Brain and Behavior Research Foundation (Young Investigator Grants 31275 and 32270) , the Paul Penningroth Fellowship in Interventional Psychiatry, and research funding from Magnus Medical. NBP was supported by grants from Dystonia Medical Research Foundation, Doris Duke Charitable Foundation, American Academy of Neurology and NIH NCATS (1KL2TR002554) . AF is funded by the Chair in Neuromodulation of University Health Network and University of Toronto. MDF was supported by grants from the NIH (R01MH113929, R21MH126271, R21NS123813, R01NS127892, R01MH130666, UM1NS132358) , the Kaye Family Research Endowment, the Ellison/Baszucki Family Foundation, the Manley Family, and Donna and Tom May. HSM is supported by grants from NIMH, NINDS, Hope for Depression Research Foundation, Wellcome Leap. MMS is supported by grants from NIA and NIMH. JCB is supported by the the Department of Defense Advanced Research Projects Agency (views, opinions and/or findings expressed are those of the author and should not be interpreted as representing the official views or policies of the Department of Defense or the U.S. Government) , the Brain & Behavior Research Foundation, the Cindy & Paul Gamble Fund, and the Marlene Zuckerman Fund, and the McLean Hospital Center of Excellence in Depression and Anxiety Disorders. JJT is primarily supported by public funds from the National Institute of Health and the Brain & Behavior Research Foundation. JAC is funded by the NIH (R01MH112737, R61MH132869, R21AG078692, R21AG081925, R21MH131878) , the AE Foundation, the Gerstner Foundation, and the Foundation for OCD Research. NRW is primarily supported by grants from the NIH (R01MH122754, UG3NS115637, R01MH128311, R01MH118388) , the Pritzker Neuropsychiatric Disorders Research Consortium (24490), the New Venture Fund (010038-2020-06-01, 011665-2020-08-01), the Wellcome Trust (220839-1), and funds from Bayshore Global Management.
- Language
- English
- Electronic publication date
- 02/21/2025
- Date published
- 03/2025
- Academic Unit
- Roy J. Carver Department of Biomedical Engineering; Neurology; Psychiatry; Stead Family Department of Pediatrics; Iowa Neuroscience Institute; Neurology (Pediatrics)
- Record Identifier
- 9984793978702771
Metrics
6 Record Views